Western Pharma Giants Paid Millions to Russian Distributors Linked to Fraud, Whistleblower Report Says
AI Summary
A whistleblower report alleges that Merck, Eli Lilly, Novartis and AstraZeneca made millions in payments to Russian distributors linked to a corruption scheme. The scheme allegedly kept medicine prices high and restricted competition in Russia’s public healthcare system.
The payments by Merck, Eli Lilly, Novartis and AstraZeneca allegedly helped fund a corruption scheme that kept drug prices high and limited competition across Russia’s public healthcare system.